Literature DB >> 11766646

[Indication and technique for shoulder endoprostheses in fractures].

A Rüter1.   

Abstract

In the treatment of fractures of the humeral head, prosthetic replacement today is accepted as part of the therapeutic repertoire. The indication for this procedure is given if alternative conservative or operative techniques of preserving the humeral head in hemiarthroplasty of the shoulder joint led to universally poor outcomes. The models of endoprostheses that are currently available on the market mainly differ in the stem fixation method and means of securing the tuberosities and rotator cuff. Functional outcome of hemiarthroplasty of the shoulder joint after trauma is less than satisfactory regardless of the type of implant. However, a stable, painless joint is obtained yielding satisfactory subjective patient outcomes. For correct indications for prosthetic replacement of a fractured humeral head the surgeon also has to know the results that can be achieved by other methods in a given situation.

Entities:  

Mesh:

Year:  2001        PMID: 11766646     DOI: 10.1007/s001040170027

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

1.  [Biomechanical investigation on refixation of tuberosities on shoulder prostheses. Does refixation with different suture materials offer enough stability?].

Authors:  J Fleischer; A Schleyer; R Nassutt; H Grundei; U Grittner; S J Hopp
Journal:  Unfallchirurg       Date:  2010-08       Impact factor: 1.000

2.  [Results after treatment of instable fractures of the proximal humerus using a fixed-angle plate].

Authors:  C Hessler; U Schmucker; G Matthes; A Ekkernkamp; R Gütschow; C Eggers
Journal:  Unfallchirurg       Date:  2006-10       Impact factor: 1.000

Review 3.  Review of fixation techniques for the four-part fractured proximal humerus in hemiarthroplasty.

Authors:  Daniel Baumgartner; Betsy M Nolan; Robert Mathys; Silvio Rene Lorenzetti; Edgar Stüssi
Journal:  J Orthop Surg Res       Date:  2011-07-18       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.